Exchange: NASDAQ·Updated 11:33 AM EDT
News
all
press releases
Pharming Group (PHAR) Securities Investigation Notice - Levi & Korsinsky
Pharming Group (PHAR) Securities Investigation Notice - Levi & Korsinsky Pharming Group (PHAR) Securities Investigation Notice - Levi & Korsinsky PR Newswire NEW YORK, Aug. 7, 2026 Pharming Group told investors to expect up to $425 million in 2026 revenue. The Company now expects as little as $375...
PR Newswire
More News
Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Pharming Group N.V. (Pharming or the Company) (NASDAQ: PHAR) investors concerning the Companys possible violations of the federal securities laws...
Business Wire
Pharming Group N.V. (PHAR) Shareholders Who Lost Money Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
Law Offices of Howard G. Smith announces an investigation on behalf of Pharming Group N.V. (Pharming or the Company) (NASDAQ: PHAR) investors concerning the Companys possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PHARMING GROUP N.V. (PHAR), CONTACT THE...
Business Wire
Securities Fraud Investigation Into Pharming Group N.V. (PHAR) Announced Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
The Law Offices of Frank R. Cruz announces an investigation of Pharming Group N.V. (Pharming or the Company) (NASDAQ: PHAR) on behalf of investors concerning the Companys possible violations of federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON PHARMING GROUP N.V. (PHAR), CLICK HERE...
Business Wire
PHAR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Pharming Group
PHAR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Pharming Group PHAR SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Pharming Group PR Newswire NEW YORK, Aug. 3, 2026 On May 7, 2026, Pharming...
PR Newswire
DBV Technologies (DBVT) Soars 5.3%: Is Further Upside Left in the Stock?
DBV Technologies (DBVT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Pharming Group N.V. Sponsored ADR (NASDAQ:PHAR - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the five brokerages that are presently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and three hav...
MarketBeat
Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Time to Buy?
Pharming Group (OTCMKTS:PHGUF) Shares Gap Up - Here's What Happened...
MarketBeat
Pharming Group (PHAR) Expected to Announce Quarterly Earnings on Thursday
Pharming Group (NASDAQ:PHAR) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-pharming-group-stock...
MarketBeat
Pharming Group (PHGUF) to Release Quarterly Earnings on Thursday
Pharming Group (OTCMKTS:PHGUF) will be releasing earnings before the market opens on Thursday, May 7. (View Earnings Report at...
MarketBeat

Advertisement|Remove ads.